Evidence map›Paper›PMID 30138343›Full record

Trial reportPloS one2018

Prediction of clinically relevant adverse drug events in surgical patients.

Jacqueline M Bos, Gerard A Kalkman, Hans Groenewoud, Patricia M L A van den Bemt, Peter A G M De Smet, J Elsbeth Nagtegaal, Andre Wieringa, Gert Jan van der Wilt, Cornelis Kramers

Open access · goldAbstract readClinical Trial
In one paragraph

Trial report in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Development of an Emergency Revisit Score for Patients With Drug-Related Problems.The Journal of pharmacy technology : jPT : official publication of the Association of Pharmacy Technicians · 2021
    Article
  8. Observational
  9. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Jacqueline M BosDepartment of clinical pharmacy, Canisius Wilhelmina hospital, Nijmegen, the Netherlands.ORCID 0000-0003-4718-1032
Gerard A KalkmanDepartment of clinical pharmacy, Canisius Wilhelmina hospital, Nijmegen, the Netherlands.
Hans GroenewoudDepartment of health evidence, Radboud university medical center, Nijmegen, the Netherlands.
Patricia M L A van den BemtDepartment of hospital pharmacy, Erasmus university medical center, Rotterdam, the Netherlands.
Peter A G M De SmetDepartment of pharmacy, Radboud university medical center, Nijmegen, the Netherlands.
J Elsbeth NagtegaalDepartment of clinical pharmacy, Meander Medical Center, Amersfoort, the Netherlands.
Andre WieringaDepartment of clinical pharmacy, Isala hospital, Zwolle, the Netherlands.
Gert Jan van der WiltDepartment of health evidence, Radboud university medical center, Nijmegen, the Netherlands.
Cornelis KramersDepartment of clinical pharmacy, Canisius Wilhelmina hospital, Nijmegen, the Netherlands.
Radboud University Nijmegen · NLCanisius-Wilhelmina Ziekenhuis · NLErasmus MC · NLIsala · NLMeander Medisch Centrum · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundRisk stratification of hospital patients for adverse drug events would enable targeting patients who may benefit from interventions aimed at reducing drug-related morbidity. It would support clinicians and hospital pharmacists in selecting patients to deliver a more efficient health care service. This study aimed to develop a prediction model that helps to identify patients on the day of hospital admission who are at increased risk of developing a clinically relevant, preventable adverse drug event during their stay on a surgical ward.

methodsData of the pre-intervention measurement period of the P-REVIEW study were used. This study was designed to assess the impact of a multifaceted educational intervention on clinically relevant, preventable adverse drug events in surgical patients. Thirty-nine variables were evaluated in a univariate and multivariate logistic regression analysis, respectively. Model performance was expressed in the Area Under the Receiver Operating Characteristics. Bootstrapping was used for model validation.

results6780 admissions of patients at surgical wards were included during the pre-intervention period of the PREVIEW trial. 102 patients experienced a clinically relevant, adverse drug event during their hospital stay. The prediction model comprised five variables: age, number of biochemical tests ordered, heparin/LMWH in therapeutic dose, use of opioids, and use of cardiovascular drugs. The AUROC was 0.86 (95% CI 0.83-0.88). The model had a sensitivity of 80.4% and a specificity of 73.4%. The positive and negative predictive values were 4.5% and 99.6%, respectively. Bootstrapping generated parameters in the same boundaries.

conclusionsThe combined use of a limited set of easily ascertainable patient characteristics can help physicians and pharmacists to identify, at the time of admission, surgical patients who are at increased risk of developing ADEs during their hospital stay. This may serve as a basis for taking extra precautions to ensure medication safety in those patients.

Indexed as

Models, TheoreticalAgedAged, 80 and overDrug-Related Side Effects and Adverse ReactionsFemaleHospitalizationHumansInpatientsLength of StayMaleMiddle AgedPreoperative PeriodRisk Factors

Identifiers

PMID30138343
PMCPMC6107128
OpenAlexW2888420520

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.